Met Life Investment Management, LLC Ars Pharmaceuticals, Inc. Comm Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Met Life Investment Management, LLC holds 29,317 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,317
Previous 29,317
-0.0%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions